EI
FLGT icon

Ellevest Inc’s Fulgent Genetics FLGT Stock Holding History

Ellevest Inc’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-500
Closed -$15.6K – 799
2023
Q1 		$15.6K Buy
500
+499
+49,900% +$16.1K ﹤0.01% 919
2022
Q4 		$30 Sell
1
-10
-91% -$358 ﹤0.01% 1804
2022
Q3 		$0 Hold
11
– – ﹤0.01% 1682
2022
Q2 		$1K Buy
11
+5
+83% +$275 ﹤0.01% 1251
2022
Q1 		$0 Hold
6
– – ﹤0.01% 1484
2021
Q4 		$1K Hold
6
– – ﹤0.01% 1268
2021
Q3 		$1K Hold
6
– – ﹤0.01% 1259
2021
Q2 		$1K Buy
+6
New +$479 ﹤0.01% 1149

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Ellevest Inc's FLGT Position: Q2 2023 in Review

Ellevest Inc sold out of Fulgent Genetics (FLGT) in Q2 2023, closing a stake of 500 shares — an estimated $15.6K sold.

Ellevest Inc first reported a position in FLGT in Q2 2021 and held it in 8 quarters. The position peaked at $15.6K in Q1 2023. 214 funds tracked by Wall St. Rank hold FLGT as of Q2 2023.

  • Ellevest Inc reported no remaining Fulgent Genetics position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 500 Fulgent Genetics shares in Q2 2023, an estimated $15.6K.
  • Ellevest Inc first reported a position in Fulgent Genetics in Q2 2021 and held it in 8 quarters.
  • Ellevest Inc's Fulgent Genetics position peaked at $15.6K in Q1 2023.
  • 214 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.